See Remarks · Xeris Biopharma Holdings, Inc. · Common Stock
Side
SELL
Value
$723K
Shares
90.0K
Price
$8.03
Executed
Jul 1, 2026
Disclosed
Jul 2, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jul 1 executedJul 2, 2026 disclosed
XERS · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
McCulloch Kevin filed this Form 4 reporting a open-market sale of XERS on Jul 1, 2026. It became public on Jul 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
See Remarks
McCulloch Kevincik:0002031695
Issuer
Xeris Biopharma Holdings, Inc.cik:0001867096
Revision history · 0
No field has changed since this record was first ingested.
